Evidence map›Paper›PMID 42820962›Full record

ArticleNeuroradiology2026

Differentiating pituitary metastases from pituitary neuroendocrine tumors in patients with a history of malignancy: clinical and magnetic resonance imaging features and quantitative morphometric analysis.

Miduo Zhu, Jingcheng Hu, Yiwen Yang, Wensheng Wang, Peng He, Tiantian Zhang, Xiaoquan Xu, Feiyun Wu, Yan Ren, Chunhong Hu

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miduo ZhuDepartment of Radiology, First Affiliated Hospital of Soochow University, Suzhou, China.
Jingcheng HuDepartment of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou, China.
Yiwen YangDepartment of Radiology, First Affiliated Hospital of Soochow University, Suzhou, China.ORCID https://orcid.org/0009-0003-5200-9170
Wensheng WangDepartment of Radiology, Guangdong 999 Brain Hospital, Guangzhou, China.
Peng HeDepartment of Radiology, Guangdong 999 Brain Hospital, Guangzhou, China.
Tiantian ZhangDepartment of Radiology, First Affiliated Hospital of Soochow University, Suzhou, China.
Xiaoquan XuDepartment of Radiology, Jiangsu Province Hospital, Nanjing, China.
Feiyun WuDepartment of Radiology, Jiangsu Province Hospital, Nanjing, China.
Yan RenDepartment of Radiology, Huashan Hospital, Shanghai, China.ORCID https://orcid.org/0000-0001-5993-9248
Chunhong HuDepartment of Radiology, First Affiliated Hospital of Soochow University, Suzhou, China. hch5305@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare the clinical and MRI findings of pituitary metastases (PMs) and pituitary neuroendocrine tumors (PitNETs) in patients with a history of malignancy and to assess quantitative morphologic parameters in dumbbell-shaped lesions.

methodsClinical and MRI data from 13 patients with PMs and 31 patients with PitNETs were retrospectively reviewed. For 27 dumbbell-shaped lesions, quantitative linear measurements were performed, and the R value was defined as the ratio of the neck diameter to the combined suprasellar and intrasellar widths. Receiver operating characteristic analysis assessed diagnostic performance.

resultsPatients with PMs had a shorter symptom-to-detection interval (P = 0.003) and more commonly presented with headache (P = 0.004). Compared with the PitNET group, the PM group showed a higher contrast-enhanced T1-weighted signal intensity ratio (P = 0.035), more frequent pituitary stalk involvement (P = 0.024), less frequent preservation of the posterior pituitary bright spot (P < 0.001), and less frequent sellar enlargement (P = 0.010). In the subgroup with dumbbell-shaped lesions, the PM group had a smaller coronal suprasellar width (P = 0.004), smaller coronal and sagittal neck diameters, and lower coronal and sagittal R values (all P < 0.001). Coronal neck diameter and coronal R value yielded AUCs of 0.986 and 0.971, respectively.

conclusionIn patients with a history of malignancy and a newly detected sellar lesion, a shorter symptom-to-detection interval, headache, pituitary stalk involvement, loss of the posterior pituitary bright spot, marked enhancement, and limited sellar enlargement may suggest PM. In dumbbell-shaped lesions, a smaller neck diameter and lower R value may provide supplementary quantitative information for differentiating PMs from PitNETs.

Indexed as

A history of malignancyDifferential diagnosisDumbbell-shapedPituitary metastasisPituitary neuroendocrine tumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.